查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046501

血管移植物市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

Vascular Graft Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血管移植市場預計將從 2025 年的 14.1 億美元大幅成長至 2031 年的 22.1 億美元，複合年成長率為 7.78%。

這些採用合成材料和生物材料製造的專用醫療設備，對於恢復病變或受損血管的血流至關重要。推動這項需求成長的主要因素是心血管疾病和糖尿病的日益流行，這些疾病需要進行諸如搭橋手術和血液透析通路等重大外科手術。全球人口老化加劇了動脈阻塞的風險，進一步擴大了這項需求。預計到2025年，全球將有5.89億成年人患有糖尿病，凸顯了血管重組的巨大需求。這項需求也體現在以下事實：2021年全球有1,941萬人死於心血管疾病，2023年美國有131,564人開始接受末期腎功能衰竭（ESRD）治療，推動了市場的蓬勃發展。Terumo Corporation）預計其心血管業務部門2025年的銷售額將年增12.4%，也印證了這一點。然而，市場擴張的主要障礙仍然是這些器械（尤其是人工血管）的長期生物相容性和通暢性方面的挑戰。術後併發症，例如血栓症、感染疾病和子宮內膜增生，常常導致移植失敗和昂貴的再次手術。這些不良生物反應令外科醫師望而卻步。從歷史上看，合成移植物的失敗率高於自體移植物，尤其是在小血管中，這限制了合成移植物的採用，阻礙了市場規模的擴大。預計到 2025 年，全球將有超過 2 億人患有周邊動脈疾病。

市場概覽
預測期 2027-2031
市場規模：2025年 14.1億美元
市場規模：2031年 22.1億美元
複合年成長率：2026-2031年 7.78%
成長最快的細分市場 動脈瘤
最大的市場 北美洲

市場促進因素

全球心血管和周邊血管疾病盛行率的不斷上升是血管移植需求的主要促進因素。隨著動脈粥狀硬化和動脈閉塞的日益普遍，需要進行外科搭橋手術以恢復血流的需求顯著增加，這直接提升了合成和生物衍生移植物的效用。在面臨人口老化和生活方式相關風​​險因素的地區，這一趨勢尤其明顯，在這些地區，血管重建術往往是避免截肢和死亡的唯一可行選擇。根據美國心臟協會發布的《2025年心血管和中風統計更新》，2021年全球約有1,941萬人死於心血管疾病，凸顯了需要血管介入治療的患者族群規模龐大。同時，末期腎功能衰竭（ESRD）患者數量不斷增加，需要血液透析通路，這也推動了市場成長。血管移植，尤其是動靜脈（AV）移植，對於不適合自發性動靜脈瘺的患者至關重要，是長期透析治療的生命線。由於糖尿病和高血壓等合併症導致腎衰竭發病率不斷上升，該領域的需求持續成長。根據美國腎臟數據系統（USRDS）發布的《2025年年度數據報告》，光是2023年，美國就有約131,564人開始接受末期腎病（ESRD）治療。鑑於這些高需求臨床領域廣泛的商業性影響，Terumo Corporation預計其心血管事業部2025年的銷售額將比上年成長12.4%，這表明由這些治療需求驅動的市場趨勢強勁。

市場挑戰

全球血管移植物市場擴張的主要障礙在於合成裝置的長期生物相容性和通暢性問題。血栓症、感染疾病和子宮內膜增生等不良生物反應常導致移植物閉塞，需要進行複雜且昂貴的再次手術。這些併發症給醫療保健系統帶來了巨大的經濟和臨床負擔，外科醫生仍然對在小直徑血管中使用合成移植物持謹慎態度，因為此類血管的失敗率歷來較高。這種臨床信心的不足限制了現成產品的廣泛應用，導致製造商的潛在市場規模不斷萎縮。此外，大量需要持久重組的患者無法獲得現有技術的充分治療，進一步加劇了這項限制的影響。根據美國心臟協會預測，到2025年，全球將有超過2億人患有周邊動脈疾病，這是一個高度依賴手術成功的龐大群體。然而，人工移植術後較高的失敗率削弱了其作為標準療法的實用性。因此，由於移植排斥和機械故障相關的風險直接抑制了收入成長並減緩了產品推廣，市場未能充分利用不斷擴大的患者群體。

市場趨勢

在關鍵趨勢的驅動下，市場正經歷一場重大變革。微創血管內動脈瘤修復術（EVAR）技術的普及，正將競爭格局從開放性手術轉向基於導管的治療。這一趨勢旨在最大程度地減輕手術帶來的身體負擔，並縮短主動脈瘤患者的康復時間，迫使製造商開發外形更小巧、更柔軟性的血管支架系統，以適應複雜的解剖結構。Medtronic2025會計年度結構性心臟疾病和主動脈業務部門淨銷售額年增6%便印證了這一點。同時，現成的組織工程血管移植物（TEVG）的開發，為解決合成替代物相關的生物相容性問題提供了一個極具前景的方案。這些生物工程結構旨在實現靈活植入，無需自體靜脈移植，並降低了感染和排斥反應的風險。 Humacyte 公司報告稱，其無細胞組織工程血管「Symvess」在 2025 年第三季的銷售額達到 703,000 美元，這表明該技術已取得商業性的進步，為創傷和血管修復提供了即用型生物導管，並表明其已早期進入市場。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血管移植物市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（血液透析通路移植、血管內血管支架、周邊血管移植、冠狀動脈繞道手術移植）
    • 依應用領域（動脈瘤、腎衰竭、血管阻塞、冠狀動脈疾病、其他應用）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血管移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血管移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血管移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血管移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血管移植市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球血管移植物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • Braun Melsungen AG
  • Bard Peripheral Vascular Inc.
  • Cordis Corporation
  • Cook Medical LLC
  • Endologix Inc.
  • Getinge Group
  • LeMaitre Vascular Inc.
  • Medtronic PLC
  • Terumo Medical Corporation.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16336

The global vascular graft market is projected to expand significantly, from USD 1.41 billion in 2025 to USD 2.21 billion by 2031, with a 7.78% CAGR. These specialized medical devices, crafted from synthetic or biological materials, are essential for restoring blood flow in diseased or damaged vessels. This growth is primarily fueled by the escalating prevalence of cardiovascular diseases and diabetes, which necessitate critical surgical interventions such as bypass procedures and hemodialysis access. An aging global population, increasingly susceptible to arterial obstructions, further amplifies this demand, with approximately 589 million adults living with diabetes globally in 2025, underscoring the immense need for vascular reconstruction. This need is further evidenced by 19.41 million global deaths from cardiovascular disease in 2021 and 131,564 people starting ESRD treatment in the US in 2023, driving strong market activity as reflected by Terumo Corporation's 12.4% year-on-year revenue increase in its Cardiac and Vascular Company segment in 2025. However, a major impediment to market expansion is the persistent challenge regarding the long-term biocompatibility and patency of these devices, especially synthetic grafts. Post-operative complications like thrombosis, infection, and intimal hyperplasia frequently lead to graft failure and costly re-interventions. These adverse biological responses deter surgeons, particularly for small-diameter vessels where synthetic grafts historically show higher failure rates compared to autologous options, limiting widespread adoption and hindering market capitalization on the more than 200 million people globally affected by peripheral artery disease in 2025.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.41 Billion
Market Size 2031USD 2.21 Billion
CAGR 2026-20317.78%
Fastest Growing SegmentAneurysms
Largest MarketNorth America

Market Driver

The escalating global prevalence of cardiovascular and peripheral vascular diseases is the foremost determinant propelling the demand for vascular grafts. As atherosclerosis and arterial obstructions become more widespread, the necessity for surgical bypass procedures to restore blood flow significantly increases, directly boosting the utility of synthetic and biological grafts. This trend is particularly acute in regions dealing with aging populations and lifestyle-associated risk factors, where vascular reconstruction is often the only viable option to prevent amputation or mortality. According to the American Heart Association, in the '2025 Heart Disease and Stroke Statistics Update', cardiovascular disease accounted for approximately 19.41 million global deaths in 2021, a figure that highlights the critical scale of the patient population requiring potential vascular interventions. Simultaneously, the increasing incidence of End-Stage Renal Disease (ESRD) requiring hemodialysis access acts as a parallel growth catalyst. Vascular grafts, particularly arteriovenous (AV) grafts, are essential for patients who are unsuitable for native fistulas, serving as a vital lifeline for long-term dialysis therapy. This segment is witnessing sustained volume growth as kidney failure rates rise due to comorbidities like diabetes and hypertension. According to the United States Renal Data System, in the '2025 Annual Data Report', approximately 131,564 people started treatment for ESRD in the United States in 2023 alone. Reflecting the broader commercial impact of these high-demand clinical areas, according to Terumo Corporation, in 2025, revenue in its Cardiac and Vascular Company segment increased by 12.4% year-on-year, signaling robust market activity driven by these therapeutic needs.

Market Challenge

The major impediment restricting the expansion of the Global Vascular Graft Market is the persistent issue regarding the long-term biocompatibility and patency of synthetic devices. Adverse biological responses, specifically thrombosis, infection, and intimal hyperplasia, frequently result in graft occlusion, necessitating complex and expensive re-interventions. These complications create a substantial economic and clinical burden on healthcare systems, causing surgeons to remain hesitant about adopting synthetic grafts for small-diameter vessels where failure rates are historically elevated. This lack of clinical confidence limits the widespread utilization of off-the-shelf commercial products, thereby reducing the total addressable market for manufacturers. The impact of this limitation is magnified by the sheer volume of patients requiring durable revascularization who are currently underserved by existing technology. According to the American Heart Association, in 2025, peripheral artery disease affected more than 200 million people globally, representing a vast demographic critically dependent on successful surgical outcomes. However, the high probability of post-operative failure in synthetic options undermines their viability as a standard of care. Consequently, the market struggles to capitalize on this growing patient base, as the risks associated with graft rejection and mechanical failure directly dampen revenue growth and slow the rate of product penetration.

Market Trends

The market is undergoing significant transformation driven by key trends. The adoption of minimally invasive Endovascular Aneurysm Repair (EVAR) techniques is shifting the competitive landscape from open surgical procedures to catheter-based interventions. This trend, aimed at minimizing operative trauma and reducing recovery times for patients with aortic aneurysms, compels manufacturers to develop lower-profile and more flexible stent-graft systems to accommodate complex anatomies, as demonstrated by Medtronic plc's 6% year-over-year net sales increase in its Structural Heart & Aortic division in fiscal year 2025. Concurrently, the development of off-the-shelf Tissue-Engineered Vascular Grafts (TEVGs) offers a promising solution to the biocompatibility issues associated with synthetic alternatives. These bioengineered constructs are designed for universal implantation, eliminating the need for autologous vein harvesting and reducing risks of infection and rejection. The commercial progression of this technology, providing immediate biological conduits for trauma and vascular repair, is highlighted by Humacyte, Inc.'s reported sales of $703,000 for its acellular tissue-engineered vessel, Symvess, in the third quarter of 2025, signaling its initial market penetration.

Key Market Players

  • Abbott Laboratories
  • Braun Melsungen AG
  • Bard Peripheral Vascular Inc.
  • Cordis Corporation
  • Cook Medical LLC
  • Endologix Inc.
  • Getinge Group
  • LeMaitre Vascular Inc.
  • Medtronic PLC
  • Terumo Medical Corporation.

Report Scope

In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Graft Market, By Product

  • Hemodialysis Access Graft
  • Endovascular Stent Graft
  • Peripheral Vascular Graft
  • Coronary Artery By-pass Graft

Vascular Graft Market, By Application

  • Aneurysms
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Diseases
  • Other Applications

Vascular Graft Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.

Available Customizations:

Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vascular Graft Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
    • 5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Vascular Graft Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vascular Graft Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Vascular Graft Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Vascular Graft Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Vascular Graft Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Vascular Graft Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Vascular Graft Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Vascular Graft Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Vascular Graft Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Vascular Graft Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Vascular Graft Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vascular Graft Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Vascular Graft Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Vascular Graft Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Vascular Graft Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Vascular Graft Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Vascular Graft Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Vascular Graft Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Vascular Graft Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Vascular Graft Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Vascular Graft Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Vascular Graft Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Vascular Graft Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Vascular Graft Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vascular Graft Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Braun Melsungen AG
  • 15.3. Bard Peripheral Vascular Inc.
  • 15.4. Cordis Corporation
  • 15.5. Cook Medical LLC
  • 15.6. Endologix Inc.
  • 15.7. Getinge Group
  • 15.8. LeMaitre Vascular Inc.
  • 15.9. Medtronic PLC
  • 15.10. Terumo Medical Corporation.

16. Strategic Recommendations

17. About Us & Disclaimer